Novel paclitaxel-coated balloon angioplasty via single retrograde popliteal access for challenging superficial femoral artery and iliac artery lesions?

Main Article Content

Erdem Cetin*
Celal Selcuk Unal
Aydın Keskin
Hakan Kartal

Abstract

Objectives: We report our results regarding the use of BioPath™ paclitaxel-coated balloon catheters for superficial or distal external iliac artery revascularization via single retrograde popliteal access.


Methods: We included 105 prospective consecutive patients. Single retrograde popliteal access was achieved under ultrasound guidance with the patients laid prone. An over-the-wire atherectomy system was used if risk of distal embolization was high due to plaque intensity of the target lesion. A 4 to 7 mm-diameter BioPath™ 035 balloon catheter was used for all lesions. Follow-up at 6th month included doppler ultrasound examination for patency.


Results: Seventy-two patients (68.6%) had total SFA occlusion and 41 patients (39%) had concomitant external iliac artery involvement, out of whom 31 (29.5%) had total occlusion. Procedural success 90.5% for superficial femoral artery and 85.3% for external iliac artery. One-year patency rates in SFA and EIA were 84.8% and 80.4%, respectively


Conclusion: Single retrograde popliteal access and drug-coated balloon angioplasty may offer a useful alternative to known modalities in treatment of challenging superficial femoral artery and concomitant iliac artery lesions.

Article Details

Cetin, E., Unal, C. S., Keskin, A., & Kartal, H. (2019). Novel paclitaxel-coated balloon angioplasty via single retrograde popliteal access for challenging superficial femoral artery and iliac artery lesions?. Journal of Cardiology and Cardiovascular Medicine, 4(3), 140–143. https://doi.org/10.29328/journal.jccm.1001055
Research Articles

Copyright (c) 2019 Cetin E, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Journal of Cardiology and Cardiovascular Medicine is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.

License: Copyright © 2017 - 2025 | Creative Commons License Open Access by Journal of Cardiology and Cardiovascular Medicine is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.

With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.

Compliance 'CC BY' license helps in:

Permission to read and download
Permission to display in a repository
Permission to translate
Commercial uses of manuscript

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license. 

Aragão JA, Santos RM, Neves OMG, Aragão ICS, Aragão FMS, et al. Quality of life in patients with peripheral artery disease. J Vasc Bras. 2018; 17: 117-121. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30377420

Conte SM, Vale PR. Peripheral Arterial Disease. Heart Lung Circ. 2018; 27: 427-432. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29150158

Aboyans V, Desormais I, Lacroix P, Salazar J, Criqui MH, et al. The general prognosis of patients with peripheral arterial disease differs according to the disease localization. J Am Coll Cardiol. 2010; 55: 898-903. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20185041

Kalbaugh CA, Kucharska-Newton A, Wruck L, Lund JL, Selvin E, et al. Peripheral Artery Disease Prevalence and Incidence Estimated From Both Outpatient and Inpatient Settings Among Medicare Fee-for-Service Beneficiaries in the Atherosclerosis Risk in Communities (ARIC) Study. J Am Heart Assoc. 2017; 6: e003796. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28468784

Yamawaki M, Hirano K, Nakano M, Sakamoto Y, Takimura H, et al. Deployment of self-expandable stent for complex proximal superficial femoral artery lesions involving the femoral bifurcation with or without jailed deep femoral artery. Catheter Cardiovasc Interv. 2013; 81: 1031-1041. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22639451

Werner M. Angioplasty with drug coated balloons for the treatment of infrainguinal peripheral artery disease. Vasa. 2016; 45: 365-372. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27351416

Olinic DM, Spinu M, Olinic M, Homorodean C, Tataru DA, et al. Epidemiology of peripheral artery disease in Europe: VAS Educational Paper. Int Angiol. 2018; 37: 327-334. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29936722

Pappy R, Hennebry TA, Abu-fadel MS. Retrograde access via the popliteal artery to facilitate the re-entry technique for recalcitrant superficial femoral artery chronic total occlusions. Catheter Cardiovasc Interv. 2011; 78: 625-631. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21648050

Sangiorgi G, Lauria G, Airoldi F, Godino C, Politi L, et al. Retrograde popliteal access as bail-out strategy for challenging occlusions of the superficial femoral artery: a multicenter registry. Catheter Cardiovasc Interv. 2012; 79: 1188-1193. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22234869

Ye M, Zhang H, Huang X, Shi Y, Yao Q, et al. Retrograde popliteal approach for challenging occlusions of the femoral-popliteal arteries. J Vasc Surg. 2013; 58: 84-89. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23806253

Shi W, Yao Y, Wang W, Yu B, Wang S, et al. Combined antegrade femoral artery and retrograde popliteal artery recanalization for chronic occlusions of the superficial femoral artery. J Vasc Interv Radiol. 2014; 25: 1363-1368. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24657086

Tokuda T, Hirano K, Muramatsu T, Tsukahara R, Nakano M. A sheathless retrograde approach via the popliteal artery is useful and safe for treating chronic total occlusions in the superficial femoral artery. J Endovasc Ther. 2014; 21: 289-295. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24754289

Matsumi J, Takada T, Moriyama N, Ochiai T, Tobita K, et al. Initial and Long-Term Results of a Microcatheter-Based Retrograde Approach for the Endovascular Treatment of Chronic Total Occlusion in Iliac or Femoropopliteal Arteries. Ann Vasc Surg. 2017; 41: 176-185. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28238927

Ruzsa Z, Wojtasik-Bakalarz J, Nyerges A, Rakowski T, Kleczynski P, et al. Long-Term Follow-up After Retrograde Recanalization of Superficial Femoral Artery Chronic Total Occlusion. J Invasive Cardiol. 2017; 29: 336-339. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28974660

Wojtasik-Bakalarz J, Arif S, Chyrchel M, Rakowski T, Bartuś K, et al. Twelve months follow-up after retrograde recanalization of superficial femoral artery chronic total occlusion. Postepy Kardiol Interwencyjnej. 2017; 13: 47-52. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28344617

Palena LM, Diaz-sandoval LJ, Raja LM, Morelli L, Manzi M. Precise Retrograde Supera Stenting of the Ostium (PRESTO) of the Superficial Femoral Artery for Complex Femoropopliteal Occlusions: The PRESTO Technique. J Endovasc Ther. 2018; 25: 588-591. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29363382

Ueshima D, Ashikaga T, Shimura T, Hatano Y, Sasaoka T, et al. Popliteal Retrograde Approach is Effective and Safe for Superficial Femoral Artery Chronic Total Occlusion. Ann Vasc Dis. 2015; 8: 220-226. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26421071

Dumantepe M. Retrograde Popliteal Access to Percutaneous Peripheral Intervention for Chronic Total Occlusion of Superficial Femoral Arteries. Vasc Endovascular Surg. 2017; 51: 240-246. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28595481